Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-06 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-06 |
mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-05 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-05 |
mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |
mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |